Follow the 派林生物 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 派林生物 has recorded 23 insider filings. Market capitalisation: €10.9bn. The latest transaction was reported on 20 May 2026 (Purchase). Among the most active insiders: 黄灵谋. All data is accessible without an account.
23
Insider Decl.
0
Thresholds
€98,001
17 ops.
Buy Volume
·
6 ops.
Sell Volume
22Σ signal
Buys €98,001· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,087 of 25,571 companies
51.2
score / 100
Value
41
Quality
62
FCF yld-6.4%
Earn yld4.9%
EV/EBITDA14.3x
ROE4.4%
Gross mgn42%
Net mgn16%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
